Recent News
-
Symposium’23 Program
Program here.
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies”, March 17, 2023, 13:30 -
3e matinée Carnot Star “9-12 Recherche-Industrie” dédiée à l’Imagerie, 17 Mars 2023, 8h30
Programme ici, inscriptions ici, . -
FairEmbo en Afrique : “Ce médecin marseillais sauve des femmes avec des bouts de ficelle”
FairEmbo en Afrique : l’Embolisation-pour-tous franchit une nouvelle étape. Plus d’informations ici. -
Webinar: Discover Radiotheranostics in Nuclear Medicine (15 Sept. 2022)
Plus d’informations ici. -
Le projet EmboBio, développé au CERIMED, a reçu le prix de l’innovation AP-HM 2022
Plus d’informations sur le prix AP-HM de l’innovation 2022 ici. Plus d’informations sur le projet Embobio dans cette vidéo. -
Le CERIMED obtient la double certification ISO 9001:2015 et NF X50-900:2016 pour ses activités de prestation et d’innovation radiologiques et nucléaires pré-cliniques
Le Centre Européen de Recherche en Imagerie Médicale (CERIMED, UMS AMU CNRS 2012) a obtenu le 5 juin 2022 la double certification ISO 9001:2015 et NF-X50-900:2016 pour -
Symposium’21 Program
Program here.
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies” -
VECT-HORUS and CERIMED Announce Collaboration to Support the Development of VECT-HORUS’ Theragnostic Agents
VECT-HORUS, a biotechnology company that designs and develops vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, has announced the signing of a collaboration -
FAIR-Embo hopes to spread safe, cheap embolization around the world
We are proud to anounce that Pr Vincent Vidal (Marseille, France), Head of the Experimental Interventional Radiology Laboratory hosted at CERIMED, and colleagues have demonstrated the in vivo feasibility
Last Publications (10/466)
- Park, S, Pin-Barre, C, Luzel, B, Cousinie, S, Garrigue, P, Pellegrino, C et al.. Injectable and degradable hydrogel: in vitro drug release behavior and evaluation in a brain repair context. Int J Pharm. 2026; :127030. doi: 10.1016/j.ijpharm.2026.127030. PubMed PMID:42208824 .
- Crepet, A, Bobot, M, Cortes, E, Klitting, R, Pezzi, L, Ayhan, N et al.. Septic Shock and Severe AKI Caused by West Nile Virus in Southern France. Kidney Int Rep. 2026;11 (6):106544. doi: 10.1016/j.ekir.2026.106544. PubMed PMID:42170033 PubMed Central PMC13188089.
- Uzel, A, Gautheron, A, Lopez, O, Rossignol, G, Muller, X, Boulanger, N et al.. Fluorescence spectroscopy precorrection model robust to large variability of optical properties: application to point of care quantitative liver graft viability assessment. Biomed Opt Express. 2026;17 (5):2323-2348. doi: 10.1364/BOE.587424. PubMed PMID:42145699 PubMed Central PMC13178595.
- Gargiulo, M, Di-Rocco, C, Doche, J, Boyer, L, Soussan, J, Frandon, J et al.. Low-Cost homemade Agar-Based phantoms for Ultrasound-Guided procedure Training: A randomized educational trial. Eur J Radiol. 2026;202 :112934. doi: 10.1016/j.ejrad.2026.112934. PubMed PMID:42144013 .
- Louis, B, Roussel, T, Cruz-Dubois, T, Ding, L, Lyu, Z, Laurini, E et al.. Fluorinated Amphiphilic Dendrimer to Improve PET Imaging of Cancer. Small. 2026; :e11972. doi: 10.1002/smll.202511972. PubMed PMID:42084057 .
- Goga, A, Soussi, G, Mogenet, A, Habert, P, Fourdrain, A, Naud, R et al.. Single-center retrospective cohort study of lung cancer associated with interstitial lung disease: Prognostic factors and molecular profile. Lung Cancer. 2026;215 :109379. doi: 10.1016/j.lungcan.2026.109379. PubMed PMID:41887129 .
- Duong, QH, Le, TK, Tran, TT, Audebert, S, Camoin, L, Nguyen, NG et al.. HSP27 functional switch drives castration-resistant prostate cancer via mTOR pathway activation, highlighting promising combination therapies. J Exp Clin Cancer Res. 2026;45 (1):. doi: 10.1186/s13046-026-03695-6. PubMed PMID:41877198 PubMed Central PMC13085302.
- Cherrak, C, Guerra, X, Panneau, J, Vidal, V, Golzarian, J, Dariane, C et al.. Prostatic artery embolization for benign prostatic hyperplasia: State of the art. Diagn Interv Imaging. 2026; :. doi: 10.1016/j.diii.2026.03.002. PubMed PMID:41866253 .
- Maisons, V, Nassar, N, Cottier, JP, Barbet, C, Sautenet, B, Mercier, E et al.. Reversible cerebral lesions in adult STEC-associated hemolytic uremic syndrome. Kidney Int. 2026;109 (4):798. doi: 10.1016/j.kint.2025.08.047. PubMed PMID:41864670 .
- Baboudjian, M, Sordelli, F, Patard, JJ, Moussi, B, Graffeille, V, Basset, V et al.. Targeted and Perilesional or Systematic Biopsies in Prostate Cancer: The TARGET Clinical Trial Protocol. Eur Urol Oncol. 2026; :. doi: 10.1016/j.euo.2026.02.003. PubMed PMID:41813528 .
Dernières Publications (10/466)
- Park, S, Pin-Barre, C, Luzel, B, Cousinie, S, Garrigue, P, Pellegrino, C et al.. Injectable and degradable hydrogel: in vitro drug release behavior and evaluation in a brain repair context. Int J Pharm. 2026; :127030. doi: 10.1016/j.ijpharm.2026.127030. PubMed PMID:42208824 .
- Crepet, A, Bobot, M, Cortes, E, Klitting, R, Pezzi, L, Ayhan, N et al.. Septic Shock and Severe AKI Caused by West Nile Virus in Southern France. Kidney Int Rep. 2026;11 (6):106544. doi: 10.1016/j.ekir.2026.106544. PubMed PMID:42170033 PubMed Central PMC13188089.
- Uzel, A, Gautheron, A, Lopez, O, Rossignol, G, Muller, X, Boulanger, N et al.. Fluorescence spectroscopy precorrection model robust to large variability of optical properties: application to point of care quantitative liver graft viability assessment. Biomed Opt Express. 2026;17 (5):2323-2348. doi: 10.1364/BOE.587424. PubMed PMID:42145699 PubMed Central PMC13178595.
- Gargiulo, M, Di-Rocco, C, Doche, J, Boyer, L, Soussan, J, Frandon, J et al.. Low-Cost homemade Agar-Based phantoms for Ultrasound-Guided procedure Training: A randomized educational trial. Eur J Radiol. 2026;202 :112934. doi: 10.1016/j.ejrad.2026.112934. PubMed PMID:42144013 .
- Louis, B, Roussel, T, Cruz-Dubois, T, Ding, L, Lyu, Z, Laurini, E et al.. Fluorinated Amphiphilic Dendrimer to Improve PET Imaging of Cancer. Small. 2026; :e11972. doi: 10.1002/smll.202511972. PubMed PMID:42084057 .
- Goga, A, Soussi, G, Mogenet, A, Habert, P, Fourdrain, A, Naud, R et al.. Single-center retrospective cohort study of lung cancer associated with interstitial lung disease: Prognostic factors and molecular profile. Lung Cancer. 2026;215 :109379. doi: 10.1016/j.lungcan.2026.109379. PubMed PMID:41887129 .
- Duong, QH, Le, TK, Tran, TT, Audebert, S, Camoin, L, Nguyen, NG et al.. HSP27 functional switch drives castration-resistant prostate cancer via mTOR pathway activation, highlighting promising combination therapies. J Exp Clin Cancer Res. 2026;45 (1):. doi: 10.1186/s13046-026-03695-6. PubMed PMID:41877198 PubMed Central PMC13085302.
- Cherrak, C, Guerra, X, Panneau, J, Vidal, V, Golzarian, J, Dariane, C et al.. Prostatic artery embolization for benign prostatic hyperplasia: State of the art. Diagn Interv Imaging. 2026; :. doi: 10.1016/j.diii.2026.03.002. PubMed PMID:41866253 .
- Maisons, V, Nassar, N, Cottier, JP, Barbet, C, Sautenet, B, Mercier, E et al.. Reversible cerebral lesions in adult STEC-associated hemolytic uremic syndrome. Kidney Int. 2026;109 (4):798. doi: 10.1016/j.kint.2025.08.047. PubMed PMID:41864670 .
- Baboudjian, M, Sordelli, F, Patard, JJ, Moussi, B, Graffeille, V, Basset, V et al.. Targeted and Perilesional or Systematic Biopsies in Prostate Cancer: The TARGET Clinical Trial Protocol. Eur Urol Oncol. 2026; :. doi: 10.1016/j.euo.2026.02.003. PubMed PMID:41813528 .
Translate